SYRE · Spyre Therapeutics, Inc.
Market Cap
$7.97B
Shares
88.17M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-11 | 2,448 | $105.33 | $257,848 |
| 2026-07-22 | 961 | $102.70 | $98,695 |
| 2026-07-21 | 4,468 | $97.33 | $434,870 |
| 2026-07-20 | 821 | $100.23 | $82,289 |
| 2026-07-17 | 2,395 | $94.12 | $225,417 |
| 2026-07-16 | 56 | $102.07 | $5,716 |
| 2026-07-07 | 6,039 | $88.74 | $535,901 |
| 2026-06-30 | 6,600 | $90.16 | $595,056 |
| 2026-06-29 | 4,555 | $87.89 | $400,339 |
| 2026-06-26 | 5,392 | $88.67 | $478,109 |
| 2026-06-22 | 207,327 | $88.34 | $18,315,267 |
| 2026-06-18 | 2,977 | $87.49 | $260,458 |
| 2026-06-17 | 74 | $83.41 | $6,172 |
| 2026-06-16 | 3 | $83.58 | $251 |
| 2026-06-15 | 514 | $80.79 | $41,526 |
| 2026-06-11 | 1,753 | $75.08 | $131,615 |
| 2026-06-05 | 6 | $78.48 | $471 |
| 2026-06-03 | 73 | $69.16 | $5,049 |
Showing 1–18 of 18 settlements
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
240 filings
237 filers
Visit website
Investor relations